$CARA News Article - Cara Therapeutics Announces No Modifications in Trial Size for Phase 2 Trial of Oral KORSUVA(TM) in Chronic Kidney Disease Patients with Pruritus after Completion of Interim Statistical Assessment
https://marketwirenews.com/news-releases/cara...12152.html